OTC Markets Group Welcomes DIRTT Environmental Solutions Ltd to OTCQX
Globenewswire· 2025-06-11 11:00
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DIRTT Environmental Solutions Ltd (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, has qualified to trade on the OTCQX® Best Market. DIRTT Environmental Solutions Ltd upgraded to OTCQX from the Pink® market. DIRTT Environmental Solutions Ltd begins trading today on OTCQX under the symbol “DRTTF.” U.S. investors ...
YY Group Expands Integrated Facility Management Portfolio with 24IFM Acquisition, Projects S$17.04 Million in Revenue from Singapore's Multi-Billion Dollar Market
Globenewswire· 2025-06-11 11:00
Singapore , June 11, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”), a global leader in on-demand workforce solutions and integrated facility management (IFM), is pleased to announce the assets acquisition of the Managing Facilities Applications, which will be branded as 24IFM, marking a strategic expansion into the property and facility management sector. This move is expected to diversify YY Group's service offerings and create a new revenue stream ...
SYNCHRONY RANKS AS NO. 1 WORKPLACE IN NEW YORK
Prnewswire· 2025-06-11 11:00
Fortune magazine and Great Place to Work recognize financial leader for creating a workplace where trust, flexibility and innovation thrive for Tri-State employees STAMFORD, Conn., June 11, 2025 /PRNewswire/ -- Synchrony (NYSE: SYF), a leading consumer financing company at the heart of American commerce and opportunity, has been named No. 1 on the 2025 Fortune Best Workplaces in New York™ List by Great Place To Work®. Synchrony's award-winning workplace is driven by a simple yet powerful formula: trust, fle ...
SailPoint Announces Fiscal First Quarter 2026 Results
Globenewswire· 2025-06-11 11:00
Core Insights - SailPoint, Inc. reported strong financial results for its fiscal first quarter ended April 30, 2025, highlighting continued expansion among its customer base, particularly within Fortune 500 and Forbes Global 2000 companies [2][3] - The company emphasizes its AI and data-driven identity security platform, which is designed for extensibility and resilience, as a key factor in its consistent performance [2][3] Financial Highlights - Total Annual Recurring Revenue (ARR) reached $925 million, a 30% year-over-year increase, with SaaS ARR growing 39% year-over-year to $574 million [6][7] - Total revenue for the quarter was $230 million, reflecting a 23% year-over-year increase, with subscription revenue at $215 million, up 27% year-over-year [7][39] - The company reported a GAAP operating loss of $(185) million, or (80)% of revenue, compared to $(68) million, or (36)% of revenue in the same quarter of the previous year [7][40] Financial Outlook - For Q2 and the full year of fiscal 2026, SailPoint expects total ARR guidance of $963 to $967 million, with a year-over-year growth rate of 26% [4] - Total revenue guidance for Q2 is projected between $242 to $244 million, with a year-over-year growth rate of 22% to 23% [4] - Adjusted earnings per share (EPS) for the full year is expected to be between $0.16 to $0.20, compared to prior guidance of $0.14 to $0.18 [4] Operational Metrics - The number of customers with more than $1 million in ARR increased by 62% year-over-year, indicating strong customer retention and growth [6] - The company’s adjusted operating margin for the quarter was 10.2%, consistent with the previous year [40] Cash Flow and Balance Sheet - Cash and cash equivalents as of April 30, 2025, were $228.1 million, up from $121.3 million at the end of the previous quarter [33] - The company reported net cash used in operating activities of $(96.8) million for the quarter, compared to $(55.4) million in the same period last year [36]
Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
Prnewswire· 2025-06-11 11:00
SAN DIEGO and CALGARY, AB, June 11, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Jared Kelly as Chief Executive Officer and a member of its Board of Directors.Mr. Kelly is a successful biotech executive who has proven expertise in transformative deals and corporate strategy. Most recently, he played a central role in orchestrating the sale of Ambrx Biopharma to Johnson ...
Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
Globenewswire· 2025-06-11 11:00
MELBOURNE, Australia and INDIANAPOLIS, June 11, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), is now commercially available nationally in the United States (U.S.). Gozellix is available through Telix’s comprehensive network of distribution partners, Cardinal Health, Inc., PharmaLogic Holdi ...
Iterum Therapeutics Announces Partnership for Commercialization Services
Globenewswire· 2025-06-11 11:00
U.S. Commercial Launch of ORLYNVAHTM by Q4 2025; First Oral Penem Available in the U.S. Management to host a conference call at 4:30 p.m. ET today DUBLIN and CHICAGO, June 11, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported that it entered into a Product Commercialization Agree ...
Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial
Prnewswire· 2025-06-11 11:00
Both vaccine candidates induced robust immune responses across all antigens tested No new safety signals were observed and both vaccine candidates were well tolerated consistent with past trials Novavax continues to pursue partnering opportunities to advance further development of these programs GAITHERSBURG, Md., June 11, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanopa ...
Victoria’s Secret & Co. Reports First Quarter 2025 Results
Globenewswire· 2025-06-11 11:00
First quarter sales and operating income exceed expectations Reaffirms full year 2025 sales guidance REYNOLDSBURG, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today reported financial results for the first quarter ended May 3, 2025. “I am proud of the team and their commitment to adapting and remaining flexible in this challenging and fast-changing environment. We focused on proactively managing the business ensuring we are remaining nimble and pro ...
VERSABANK TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE ON JUNE 12, 2025, AT 2:30 PM ET
Prnewswire· 2025-06-11 11:00
LONDON, ON, June 11, 2025 /PRNewswire/ - VersaBank ("VersaBank" or the "Bank") (TSX: VBNK) (NASDAQ: VBNK), a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today announced management will participate in the Sidoti Virtual Investor Conference to be held on June 11-12, 2025. David Taylor, President of VersaBank, will present on June 12, 2025, at 2:30 p.m. ET. A live webcast of the presentation will be available on the Bank's website at https:/ ...